These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
496 related articles for article (PubMed ID: 26449892)
1. Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease. Aqel B; DiBaise JK Nutr Clin Pract; 2015 Dec; 30(6):780-6. PubMed ID: 26449892 [TBL] [Abstract][Full Text] [Related]
2. Understanding the Effects of Gut Microbiota Dysbiosis on Nonalcoholic Fatty Liver Disease and the Possible Probiotics Role: Recent Updates. Khan A; Ding Z; Ishaq M; Bacha AS; Khan I; Hanif A; Li W; Guo X Int J Biol Sci; 2021; 17(3):818-833. PubMed ID: 33767591 [TBL] [Abstract][Full Text] [Related]
3. Gut microbiota: novel therapeutic target for nonalcoholic fatty liver disease. Suk KT; Kim DJ Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):193-204. PubMed ID: 30791767 [TBL] [Abstract][Full Text] [Related]
4. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications. Jayakumar S; Loomba R Aliment Pharmacol Ther; 2019 Jul; 50(2):144-158. PubMed ID: 31149745 [TBL] [Abstract][Full Text] [Related]
5. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives. Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205 [TBL] [Abstract][Full Text] [Related]
6. Nonalcoholic Fatty Liver Disease: Basic Pathogenetic Mechanisms in the Progression From NAFLD to NASH. Pierantonelli I; Svegliati-Baroni G Transplantation; 2019 Jan; 103(1):e1-e13. PubMed ID: 30300287 [TBL] [Abstract][Full Text] [Related]
7. Periodontal treatment and microbiome-targeted therapy in management of periodontitis-related nonalcoholic fatty liver disease with oral and gut dysbiosis. Kuraji R; Shiba T; Dong TS; Numabe Y; Kapila YL World J Gastroenterol; 2023 Feb; 29(6):967-996. PubMed ID: 36844143 [TBL] [Abstract][Full Text] [Related]
8. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter? Xie C; Halegoua-DeMarzio D Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378 [TBL] [Abstract][Full Text] [Related]
9. The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota. Boursier J; Mueller O; Barret M; Machado M; Fizanne L; Araujo-Perez F; Guy CD; Seed PC; Rawls JF; David LA; Hunault G; Oberti F; Calès P; Diehl AM Hepatology; 2016 Mar; 63(3):764-75. PubMed ID: 26600078 [TBL] [Abstract][Full Text] [Related]
10. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics. Chen J; Thomsen M; Vitetta L J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932 [TBL] [Abstract][Full Text] [Related]
11. The Role of Probiotics in Nonalcoholic Fatty Liver Disease: A New Insight into Therapeutic Strategies. Meroni M; Longo M; Dongiovanni P Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689910 [TBL] [Abstract][Full Text] [Related]
12. Modulation of gut microbiome in nonalcoholic fatty liver disease: pro-, pre-, syn-, and antibiotics. Cho MS; Kim SY; Suk KT; Kim BY J Microbiol; 2018 Dec; 56(12):855-867. PubMed ID: 30377993 [TBL] [Abstract][Full Text] [Related]
15. Gut microbiota abnormalities, small intestinal bacterial overgrowth, and non-alcoholic fatty liver disease: An emerging paradigm. Ghoshal UC; Goel A; Quigley EMM Indian J Gastroenterol; 2020 Feb; 39(1):9-21. PubMed ID: 32291578 [TBL] [Abstract][Full Text] [Related]
16. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation. Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642 [TBL] [Abstract][Full Text] [Related]
17. Nonalcoholic Fatty Liver Disease and the Gut Microbiome. Boursier J; Diehl AM Clin Liver Dis; 2016 May; 20(2):263-75. PubMed ID: 27063268 [TBL] [Abstract][Full Text] [Related]
18. Longitudinal 16S rRNA Sequencing Reveals Relationships among Alterations of Gut Microbiota and Nonalcoholic Fatty Liver Disease Progression in Mice. Zhuge A; Li S; Lou P; Wu W; Wang K; Yuan Y; Xia J; Li B; Li L Microbiol Spectr; 2022 Jun; 10(3):e0004722. PubMed ID: 35647690 [TBL] [Abstract][Full Text] [Related]
19. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. Miura K; Ohnishi H World J Gastroenterol; 2014 Jun; 20(23):7381-91. PubMed ID: 24966608 [TBL] [Abstract][Full Text] [Related]
20. Obesity, fatty liver disease and intestinal microbiota. Arslan N World J Gastroenterol; 2014 Nov; 20(44):16452-63. PubMed ID: 25469013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]